FDA Approves Guselkumab Injector

The FDA has approved a single-press, self-injection device for a 100-mg dose of guselkumab for adults with moderate to severe plaque psoriasis...

Source: The Rheumatologist - March 20, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates Source Type: research